TrialDrugs in R&D2012

Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.

Carlos Casas-Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.